Stephen Friend Explained

Stephen H. Friend is co-founder and director of Sage Bionetworks.[1] [2] [3]

Formerly Senior Vice-president at Merck & Co. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996.[4] Much of his research has focused on cancer.[5]

Friend has also held faculty positions at Harvard Medical School and at Massachusetts General Hospital. He received his Bachelor of Arts in philosophy, his Ph.D. in biochemistry and his M.D. from Indiana University.[2]

Recognition

Friend is named an Ashoka Fellow by in 2011.[6]

Selected bibliography

External links

Notes and References

  1. 10.1126/science.335.6069.651. 22323794. The Visionary. Science. 335. 6069. 651–3. 2012. Kaiser. J..
  2. Web site: Sage Bionetworks Seattle | Directors . https://web.archive.org/web/20120127081638/http://sagebase.org/info/directors.php . 2012-01-27 . 2012-02-11 . dead .
  3. 10.1038/nrd2509. Stephen Friend. Nature Reviews Drug Discovery. 7. 2. 114. 2008. free.
  4. 10.1038/458013a. 19262635. Something wiki this way comes. Nature. 458. 7234. 13. 2009. Nelson. Bryn. Schadt. E. free.
  5. 10.1126/science.335.6069.651 . 22323794 . The Visionary . Science . 335 . 6069 . 651–3 . 2012 . Kaiser . J. .
  6. http://sagebase.org/info/NewsInfoDownloads/SageAshokaRelease6APR2011.pdf{{Dead link|date=August 2017}}